It is not clear whether the risk of mutations in the Breast Cancer Gene 1 (BRCA1) and Breast Cancer Gene 2 (BRCA2) genes can be implicated in the etiology of both breast and ovarian cancers, given the high incidence of female breast cancer globally, in Uganda, or probably due to the improvement in the radiological and immunobiological diagnosis of cancers [16, 17]. The gene discussed is BRCA1; the disease is ovarian cancer.